Shenzhen New Industries Biomedical Engineering Co., Ltd.
300832
Rangering i aksjer
#2881
Shenzhen New Industries Biomedical Engineering Co., Ltd., engages in the... Shenzhen New Industries Biomedical Engineering Co., Ltd., engages in the research, development, production, and sale of clinical laboratory instruments and in vitro diagnostic reagents to hospitals in China and internationally. It offers immunoassay machine, biochemistry/electrolyte, integrated system, lab automation, molecular diagnostics, hemolumi and rapid test solutions. The company was founded in 1995 and is based in Shenzhen, China.
Aksjekurs
$8.03
Markedsverdi
$6.31B
Endring (1 dag)
1.07%
Endring (1 år)
-8.04%
Land
CN
Handel Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832)
Kategori
Healthcare
Utbyttehistorikk for Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832)
Shenzhen New Industries Biomedical Engineering Co., Ltd. (aksjesymbol: 300832) har gitt totalt 7 utbyttebetalinger.
Summen av alle utbytter (justert for aksjesplitt): $6.12
Utbytteavkastning (TTM): 0.0224
Summen av alle utbytter (justert for aksjesplitt): $6.12
Utbytteavkastning (TTM): 0.0224
Utbyttebetalinger for Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832) fra 2020 til 2026
Årlige utbyttebetalinger
| År | Utbytte (justert for aksjesplitt) | Endre |
|---|---|---|
| 2026 (TTM) | $1.20 | -7.69% |
| 2025 | $1.30 | 30.00% |
| 2024 | $1.00 | 42.86% |
| 2023 | $0.7 | 16.67% |
| 2022 | $0.6 | 14.00% |
| 2021 | $0.5263 | -33.34% |
| 2020 | $0.7895 | 0.00% |
Liste over alle utbyttebetalinger
| År | Utbytte | Endre |
|---|---|---|
| 2026 (TTM) | $1.20 | -7.69% |
| 2025 | $1.30 | 30.00% |
| 2024 | $1.00 | 42.86% |
| 2023 | $0.7 | 16.67% |
| 2022 | $0.6 | -40.00% |
| 2021 | $1.00 | -33.33% |
| 2020 | $1.50 | 0.00% |
Utbyttebetalinger for lignende selskaper eller konkurrenter
| Selskap | Antall utbyttebetalinger | Land |
|---|---|---|
| 176.00% |
US
|
|
| 181.00% |
IE
|
|
| 87.00% |
US
|
|
| 0.00% |
US
|
|
| 8.00% |
DE
|
